Sepsis in severe COVID-19 is rarely septic shock: a retrospective single-centre cohort study

Br J Anaesth. 2021 Nov;127(5):e182-e185. doi: 10.1016/j.bja.2021.08.007. Epub 2021 Aug 17.

Authors

Pietro Arina¹, Valeria Moro¹, Beatrice Baso¹, Christopher Baxter-Derrington², Mervyn Singer³

Affiliations

¹ Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK.
² Health Intelligence, Medicine Board, University College London Hospitals NHS Foundation Trust, London, UK.
³ Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK. Electronic address: m.singer@ucl.ac.uk.

No abstract available

Keywords: COVID-19; hyperlactataemia; sepsis; sepsis-3; septic shock.

Publication types

Letter

MeSH terms

Aged
COVID-19 / complications*
COVID-19 Drug Treatment
Cohort Studies
Critical Care
Female
Humans
Lactic Acid / blood
Male
Middle Aged
Retrospective Studies
Sepsis / drug therapy
Sepsis / etiology*
Shock, Septic / drug therapy
Shock, Septic / etiology*
Vasoconstrictor Agents / therapeutic use

Substances

Vasoconstrictor Agents
Lactic Acid